- Solid financial performance:
- Sales at constant exchange rates: up 6.5%
- Including organic growth: up 4.1%
- Operating margin before non-recurring items: 18%
- Confirmed medium and long-term growth potential, supported by:
- Innovation and a robust product pipeline
- International expansion
- Targeted acquisitions and partnerships
Download
- Filename
- pr_biomerieux_2011_results_en.pdf
- Size
- 279 KB
- Format
- application/pdf